Uncategorized

Sonire Therapeutics Awarded $13 Million Through NEDO Deep-Tech Startups Support Program (DTSU) to Advance Global Commercialization of Pancreatic Cancer Treatment

New Energy and Industrial Technology Development Organization's (NEDO) Deep-Tech Startups Support Program, which is one of Japan's largest government-backed initiatives focused on accelerating the commercialization of breakthrough technologies.

read more
421 120 Bernice Tan

Sonire Therapeutics raises $18M Series A for pancreatic cancer treatment

Sonire Therapeutics has raised $18m towards supporting the ongoing clinical advancement of its non-invasive thermal ablation tumour treatment system. The Tokyo, Japan-headquartered company’s Series A financing round was led by Santé Ventures, with additional participation from investors including Fast Track Initiative (FTI), Nomura SPARX Investment, and SBI Investment.

read more
421 120 Bernice Tan